Viewing Study NCT00423800

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-26 @ 12:19 PM

Ignite Modification Date: 2025-12-29 @ 3:58 PM

Study NCT ID: NCT00423800

Status: TERMINATED

Last Update Posted: 2017-04-07

First Post: 2007-01-17

Is Gene Therapy: True

Has Adverse Events: True

Brief Title: Efficacy and Safety of 24 vs 48 Weeks of Pegetron® (Peginterferon Alfa-2b + Ribavirin) in Naïve Genotype 1 Hepatitis C (Study P05016)(TERMINATED)

Sponsor: Merck Sharp & Dohme LLC

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Adverse Events Module Baseline Characteristics Module Participant Flow Module